USP Pharmaceutical Analytical Impurities

(2-(4-Nitro-1H-imidazol-1-yl)ethanol)

(2-(tert-butylamino)-1-[4-ethoxy-3-(hydroxymethyl)phenyl]ethan-1-ol 2,2,2-trifluoroacetate)

(4-[2-(tert-Butylamino)-1-hydroxyethyl]-2-ethylphenol hydrobromide)

(3-Ethyl 5-methyl 2,6-bis[(2-aminoethoxy)methyl]- 4-(2-chlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylate)

(2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine-3-carboxylic acid)

(6-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-5-(ethoxycarbonyl)-2-methyl-1,4-dihydropyridine-3-carboxylic acid)

(3-Ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(2-[(2-hydroxyethyl)carbamoyl]benzamido)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate)

(21-(Acetyloxy)-9-chloro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate)

(9-Chloro-11beta-hydroxy-16beta-methyl-3,20-dioxo-17-propionyloxypregna-1,4-diene-21-yl butyrate)

(2-(tert-Butylamino)-1-(3,5-dichlorophenyl)propan-1-one hydrochloride)

(2-Amino-1-(3-chloro-phenyl)-1-propanone 4-methylbenzenesulfonate)

(Ethyl 2-(4-chloro-3-sulfamoylbenzoyl)benzoate)

(2-Chloro-5-(1-ethoxy-3-oxoisoindolin-1-yl)benzenesulfonamide)

(2-Chloro-5-(3-oxoisoindolin-1-yl)benzenesulfonamide)

(2-Chloro-5-(1-isopropoxy-3-oxoisoindolin-1-yl)benzenesulfonamide)

(Isopropyl 2-(4-chloro-3-sulfamoylbenzoyl)benzoate)

(3-(4-Chlorophenyl)-3-hydroxyisoindolin-1-one)

(6alpha,9-Difluoro-11beta,21,21-trihydroxy-16alpha,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione)

(11beta,21-Dihydroxy-3,20-dioxopregna-4-en-17-yl acetate)

((11beta,17alpha)-11,17-Dihydroxy-3-oxoandrost-4-ene-17-carboxylic acid)

((cis-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl methanesulfonate)

((S)-2-Acetamido-3-(4-acetoxy-3, 5-diiodophenyl)propanoic acid)

(4-[4-(2-Aminoethyl)-2,6-diiodophenoxy]-2-iodophenol)

(2-Hydroxy-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid)